Virtual nature escape could calm dialysis patients
NCT ID NCT07704008
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study tests whether wearing virtual reality glasses and watching a calming nature video during hemodialysis can help lower anxiety and keep vital signs stable. Researchers are enrolling 56 adults who are receiving dialysis for the first time. Half will watch a 4K nature video with relaxing music through VR glasses during their session, while the other half receives standard care. The study measures changes in blood pressure, heart rate, breathing rate, oxygen levels, temperature, and anxiety scores.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- virtual reality glasses showing a 4K nature video with calming background music
- What this could lead to
- If effective, virtual reality could become a simple, drug-free way to ease anxiety and improve comfort during hemodialysis.
- What could go wrong
- This is a small, early-stage study with only 56 participants, so results may not apply to all dialysis patients. The effect may be due to the relaxing video rather than the virtual reality itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
56 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Receiving hemodialysis treatment for the first time. * Age ≥18 years. * No visual, hearing, or cognitive impairment. * Able to communicate effectively. * Clinically stable. * No diagnosed psychiatric disorder or use of psychiatric medication. * No history of seizures. * Willing and able to provide informed consent. Exclusion Criteria: * Previous hemodialysis treatment. * Age \<18 years. * Visual, hearing, or cognitive impairment. * History of kidney transplantation. * Communication difficulties. * Diagnosed psychiatric disorder or use of psychiatric medication. * History of seizures. * Declined to participate in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hemodialysis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Ankara, 06200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will progress quickly to kidney failure?
- Can a simple body scan replace guesswork in dialysis fluid removal?
- Family talks may ease the toll of kidney dialysis
- Can a new preservation fluid keep donor kidneys healthier for transplant?
- Can light therapy speed up dialysis fistula healing?
- Extra vaccine dose: could it shield dialysis patients from hepatitis b?